With chronic heart failure still a leading cause of death in the U.S., medical device companies are releasing innovative products to help manage the disease. The FDA recently cleared Withings’ BPM Pro 2 cellular blood pressure monitor, designed for remote monitoring of heart failure patients. The monitor allows clinicians to program questions for patients to answer at home, gathering information on medication adherence and symptoms. This feature can help care teams spend more quality time with patients, addressing the current workforce shortage in healthcare. The device also ensures measurement accuracy and prompts users to retake measurements and schedule appointments. Available for purchase in the U.S. on January 1.
Source link
FDA Clears Withings’ New Blood Pressure Monitor That Allows Providers to Communicate Directly with Patients
